SCHEMBL6287930

SCHEMBL6287930

NCCC[C@@H](NC(=O)Cc1c[nH]c2ccccc12)C(=O)Nc1ccc(C(OC(=O)C(F)(F)F)(c2ccc(NC(=O)[C@@H](CCCN)NC(=O)Cc3c[nH]c4ccccc34)cc2)c2ccc(NC(=O)[C@@H](CCCN)NC(=O)Cc3c[nH]c4ccccc34)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.46
MAPT P10636 1/20 0.46
PTBP1 P26599 1/20 0.46
HTT P42858 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HDAC1 Q13547 8/20 0.44
HDAC8 Q9BY41 6/20 0.44
HDAC3 O15379 5/20 0.44
HDAC4 P56524 5/20 0.44
HDAC7 Q8WUI4 5/20 0.44
HDAC2 Q92769 5/20 0.44
HDAC10 Q969S8 5/20 0.44
HDAC11 Q96DB2 5/20 0.44
HDAC6 Q9UBN7 5/20 0.44
HDAC9 Q9UKV0 5/20 0.44
HDAC5 Q9UQL6 5/20 0.44
KDM1A O60341 1/20 0.43
MAOA P21397 1/20 0.43
MC4R P32245 1/20 0.43
MC5R P33032 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6290843 0.98 LMNA (0.46) LMNAMAPTPTBP1HTTSMN1; SMN2
Trifluoroacetic Acid SCHEMBL6287928 0.84 SMN1; SMN2 (0.46) LMNAMAPTPTBP1HTTSMN1; SMN2
Trifluoroacetic Acid SCHEMBL6290840 0.82 LMNA (0.46) LMNAMAPTPTBP1HTTSMN1; SMN2
Trifluoroacetic Acid SCHEMBL6284172 0.81 GHSR (0.45) LMNAMAPTPTBP1HTTSMN1; SMN2
SCHEMBL6288024 0.81 LTA4H (0.46) HDAC1HDAC8HDAC3HDAC4HDAC7
SCHEMBL6286285 0.81 LTA4H (0.46) HDAC1HDAC8HDAC3HDAC4HDAC7
Hydrochloric Acid SCHEMBL6290968 0.80 HDAC1 (0.49) SMN1; SMN2HDAC1HDAC8HDAC3HDAC4
Hydrochloric Acid SCHEMBL6286774 0.80 HDAC1 (0.49) SMN1; SMN2HDAC1HDAC8HDAC3HDAC4
Trifluoroacetic Acid SCHEMBL6288009 0.79 SMN1; SMN2 (0.47) LMNAMAPTPTBP1HTTSMN1; SMN2
SCHEMBL6288012 0.78 ALDH1A1 (0.43) MAPTHTTHDAC1L3MBTL1GOT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-08-28 US claimed
EP-1291341-A1 COMPOUNDS EXHIBITING THROMBOPOIETIN-LIKE ACTIVITIES CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-03-12 EP claimed
US-6887890-B2 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2005-05-03 US disclosed
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-08-28 US disclosed
EP-1291341-A1 COMPOUNDS EXHIBITING THROMBOPOIETIN-LIKE ACTIVITIES CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-03-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities MPL, THPO, TEK LMNA 3699/4885MAPT 4866/4885PTBP1 1003/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.